Criteria for use of interferon alfa-2a or interferon alfa-2b for selected indications in adults.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000328:Adult; D002985:Clinical Protocols; D003218:Condylomata Acuminata / Q000188:drug therapy; D004363:Drug Utilization / Q000592:standards*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy; D008297:Male; D010166:Palliative Care / Q000592:standards; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D016896:Treatment Outcome
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins